EIF4A2 as another novel fusion partner of PLAG1 in lipoblastoma
The 5th edition of the WHO classification of Soft Tissue and Bone tumors recognizes lipoblastoma as a benign adipocytic tumor with excellent prognosis and a recurrence rate of 13-46%. The characteristic genomic alteration that helps separate lipoblastoma from morphologic mimics particularly myxoid l...
Saved in:
Main Authors: | Rofieda R. Alwaqfi (Author), Jonathan J. Davick (Author), Aaron D. Bossler (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PLAG1, SOX10, and Myb Expression in Benign and Malignant Salivary Gland Neoplasms
by: Ji Hyun Lee, et al.
Published: (2019) -
Novel eIF4A1 inhibitors with anti‐tumor activity in lymphoma
by: Forum Kayastha, et al.
Published: (2022) -
Supraclavicular lipoblastoma
by: Austin Lunney, et al.
Published: (2019) -
Childhood lipoblastoma
by: Ashish Lal Shrestha, et al.
Published: (2020) -
Lipoblastoma of the abdominal wall
by: Filipa Jalles, et al.
Published: (2019)